EntheoBliss
We envision a world where entheogens are safely and legally available for beneficial uses, and where research is governed by a rigorous scientific evaluation of their risks and benefits.
Healthcare Foundation
As a result of the 2020 Armenian-Azerbaijani war around 100,000 Armenians were displaced, 4088 killed, 11,000 wounded, and sick.

In accordance with our unofficial estimates, 5000-15000 veterans and civilians struggle from Post Traumatic Stress Disorder (PTSD) as a result of this war.

PTSD is a common and debilitating condition with immeasurable social and economic costs that affects the lives of hundreds of millions of people around the world annually.

After decades of criminalization, entheogenic drugs, including 3,4-methylenedioxymethamphetamine (MDMA), are on the brink of reappearing as a potential pharmacological treatment for mental health disorders and addiction.

Ongoing US FDA approved Phase 3 clinical trial demonstrated that 67% of participants who received three MDMA-assisted therapy sessions for severe PTSD no longer qualified for a PTSD diagnosis at the end of the study. In addition, close to 90% of participants reported a significant reduction in symptoms. US FDA approval may come as early as 2023.

To bring these cutting-edge entheogen-assisted healing modalities to the Armenian people EntheoBliss Healthcare Foundation, a nonprofit organization was established.
Our Story
It’s a combination of two words. Entheo (shorten from entheogen) and bliss.
Bliss means perfect happiness, great joy.

The name EntheoBliss means achieving bliss through entheogen-assisted healing modalities.
Entheogen is a chemical substance, typically of plant origin, that is ingested to produce a holotropic (non-ordinary, altered) state of consciousness for, medical, social, psychological, and spiritual purposes.
Definition of the Name
Our Goal
To achieve mass mental health through entheogen-assisted healing modalites
To achieve our goal, the foundation will be pursuing the following objectives:
To promote entheogen-assisted psychotherapy by:
Funding the research, including clinical trials.
Providing training directly or via partner organizations for psychiatrists, psychologists, and other health care and social services professionals.
To inform the public about the risks and benefits of entheogenic usage in a variety of contexts and provide honest and science-based drug education.
To publish journals, newsletters, books, and pamphlets. Organize conferences and courses of instruction in the various legal uses of entheogenic medicines.
To support research on healing modalities of intergenerational trauma.
To support research on relieving emotional and existential distress at the end of life.
To support research on rites of passage and how modern society can adapt and benefit from these traditions.
Investigate various possible roles that entheogens can play in the understanding of the difference between drug use and drug abuse and in the treatment of drug abusers.
To promote the development of a variety of entheogenic medicines that are legal, safe, and efficacious.
Collaborate with public figures and experts to develop evidence-based drug policies.
Our Values
We thrive to understand or feel what another person is experiencing from within their frame of reference, we place ourselves in another's position.
Empathy
We understand what others are going through, we empathize with them, and we show them that we love and care for them. Compassion involves a consideration of other people's values, beliefs, needs and wants in terms of which their suffering can be understood and hence be shared.
Compassion
Information is shared openly and clearly. Communications are respectful, honest, and forthright.
Transparency
Our team
Board of Trustees
MBA, Chief Innovation and Digitalization Officer, Ameriabank
Lieutenant, CARC, Peer Recovery liaison, Winthrop Police Department
Artyom Shamtsyan
Sarko Gergerian
Chairman of the Board,
Ph.D., Founder, and Executive Director, Multidisciplinary Association for Psychedelic Studies, Inc. (MAPS)
Rick Doblin
Scientific Advisory Board
Fellow of the American Psychiatric Association. Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry
Arman Danielyan
M.D., Ph.D., Honorary Fellow, World Psychiatric Association (WPA); President, Armenian Psychiatric Association; President, Armenian Medical Association; Scientific Manager, Psychosocial Recovery Center; Associate Professor, Yerevan State Medical University; Editor in Chief, Armenian Journal of Mental Health.
Armen Soghoyan
MSW, LCSW; Senior Clinical Project Director, Veterans Emergency Management Evaluation Center (VEMEC)
Sona Hovsepian
Ph.D. - Supervisor and Trainer for MAPS:
MDMA Assisted Psychotherapy for PTSD, Clinical Supervisor, and Senior member: ITA: The Israeli Association for Behavior and Cognitive Psychotherapies; Clinical Supervisor and Senior member: EACBT: European Association for Behavioural and Cognitive Therapies.
Naftali Halberstadt
Director of the IDeA Charitable Foundation; Head of foundation affairs for the HENAR Foundation
Armen Minassian
Staff
Founder and Executive Director
Sergey Vardanyan
MD, PhD Principal Investigator, MDMA assisted psychotherapy for PTSD Clinical trial, Professor at the Department of Psychiatry at the Yerevan Medical University, President of the Association of Child Psychiatrists and Psychologists of Armenia,
Member of the Board of the International Academy of Neurosciences.
Maruke Yeghiyan
Projects
PTSD is a serious, debilitating disorder that negatively impacts a person’s daily life, and can result in diminished cognitive and psychosocial functioning, fractured relationships, inability to maintain employment, substance abuse, high-cost healthcare utilization, increased depression, and suicide risk.
MDMA assisted psychotherapy for PTSD in Armenia
Donate
EntheoBliss relies on the generosity of individual donors such as you. The future of entheogenic research depends on individual donors. Please consider making a donation today.
approximately USD (according to CBA rate)



EntheoBliss relies on the generosity of individual donors such as you. The future of entheogenic research depends on individual donors.
Please consider making a donation today.
For Bank Transfers
INTERMEDIARY BANK: CITIBANK NA, NEW YORK
SWIFT (BIC): CITIUS33

BENEFICIARY’S BANK: AMERIABANK, YEREVAN
BENEFICIARY’S BANK SWIFT (BIC): ARMIAM22

BENEFICIARY’S ACCOUNT USD: 1570077292030101
BENEFICIARY’S ACCOUNT AMD: 1570077292030100
BENEFICIARY’S ACCOUNT EURO: 1570077292030146
BENEFICIARY’S ACCOUNT RUB: 1570077292030158

BENEFICIARY’S NAME: ENTHEOBLISS HEALTHCARE FOUNDATION
DETAILS OF PAYMENT: DONATION
© 2022 Entheo Bliss
All Rights Reserved.